| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/12/2006 | US20060009619 Polypeptide sequences related to ricin A chain but lack or have reduced detectable N-glycosidase-rRNA activity; treating or preventing ricin intoxication |
| 01/12/2006 | US20060009385 Multiple-variable dose regimen for treating TNFalpha-related disorders |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/12/2006 | US20060009382 Use of a CD28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect |
| 01/12/2006 | US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics |
| 01/12/2006 | US20060008901 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/12/2006 | US20060008900 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene |
| 01/12/2006 | US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases |
| 01/12/2006 | US20060008883 Using vector transformation to generate protein fusions with reduced immunogenicity; directed protein evolution |
| 01/12/2006 | US20060008882 Antibody or fragment that specifically binds to CK alpha -5 polypeptides; may be chimeric antibody or fragment thereof, a single chain antibody, a Fab fragment, or a F(ab')2 fragment; Western blot or an enzyme-linked immunosorbent assay; hybridoma that produces the antibody |
| 01/12/2006 | US20060008877 Expression systems with sec-system secretion |
| 01/12/2006 | US20060008876 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 01/12/2006 | US20060008858 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 01/12/2006 | US20060008857 Cap-binding protein |
| 01/12/2006 | US20060008853 Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same |
| 01/12/2006 | US20060008814 Method for determining a risk of atherosclerosis or future development of atherosclerotic complications |
| 01/12/2006 | US20060008798 Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same |
| 01/12/2006 | US20060008474 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 01/12/2006 | US20060008465 Novel methods for therapeutic vaccination |
| 01/12/2006 | US20060008461 Delivering into phagocytic cells; targeting specific organelles; inhibiting, attenuating, arresting, combating and overcoming microbial infection of phagocytic mammalian cells in vivo and in vitro |
| 01/12/2006 | US20060008460 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease |
| 01/12/2006 | US20060008459 Combination therapy of respiratory diseases using antibodies |
| 01/12/2006 | US20060008458 Prevention of brain inflammation as a result of induced autoimmune response |
| 01/12/2006 | US20060008457 Use of an active substance binding to CD28 for producing a pharmaceutical composition for the treatment of B-CLL |
| 01/12/2006 | US20060008456 Natural humanized antibody |
| 01/12/2006 | US20060006827 Motor control apparatus having current supply phase correction |
| 01/12/2006 | DE102004031116A1 Verfahren zum Auffinden schmerzrelevanter Substanzen unter Verwendung schmerzrelevanter Proteine A method for finding relevant substances pain using pain-relevant proteins |
| 01/12/2006 | CA2601417A1 Antibodies binding to receptors kir2dl1, -2, 3 but not kir2ds4 and their therapeutic use |
| 01/12/2006 | CA2572321A1 Anti-synoviolin antibody |
| 01/12/2006 | CA2572318A1 Treatment of cancer |
| 01/12/2006 | CA2572133A1 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 01/12/2006 | CA2571957A1 Methods and compositions using cd3 agonists |
| 01/12/2006 | CA2571799A1 Anti-il-13 immunoglobulins |
| 01/12/2006 | CA2571536A1 Compositions and methods for treating inflammatory disorders |
| 01/12/2006 | CA2569557A1 Treatment of bacterial infections |
| 01/11/2006 | EP1614752A2 Novel human 7TM proteins and polynucleotides encoding the same |
| 01/11/2006 | EP1614749A1 Method of constructing hybridoma producing antigen-specific antibody using single antigen-specific b lymphocyte and method of producing monoclonal antibody |
| 01/11/2006 | EP1614693A1 Purification of human monoclonal antibody and human polyclonal antibody |
| 01/11/2006 | EP1614692A2 ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
| 01/11/2006 | EP1614690A1 Peptide fragment of lyve-1 and antibody against the same |
| 01/11/2006 | EP1613961A2 Surface receptor complexes as biomarkers |
| 01/11/2006 | EP1613751A1 Method for the construction of randomized gene sequence libraries in cells |
| 01/11/2006 | EP1613750A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 01/11/2006 | EP1613743A1 Fetal cell isolation and enrichment |
| 01/11/2006 | EP1613736A2 Inhibition of viral pathogenesis |
| 01/11/2006 | EP1613732A2 Intracellular complexes as biomarkers |
| 01/11/2006 | EP1613660A2 Compositions and methods relating to stop-1 |
| 01/11/2006 | EP1613659A1 New monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 01/11/2006 | EP1613658A2 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/11/2006 | EP1613657A2 Anti-amyloid antibodies, compositions, methods and uses |
| 01/11/2006 | EP1613656A1 Cancerous disease modifying antibodies |
| 01/11/2006 | EP1613655A1 Clostridium difficile focussed antibodies |
| 01/11/2006 | EP1613654A2 Antibodies with enhanced ability to immunomodulate cell functions |
| 01/11/2006 | EP1613650A2 Severe acute respiratory syndrome (sars) causing coronavirus |
| 01/11/2006 | EP1613643A2 Lupus antibodies for passive immunotherapy of hiv/aids |
| 01/11/2006 | EP1613350A2 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor |
| 01/11/2006 | EP1613349A2 Immunogenic recombinant antibody |
| 01/11/2006 | EP1613348A2 Methods for modulating angiogenesis with apelin compositions |
| 01/11/2006 | EP1613347A2 Humanized antibodies that recognize beta amyloid peptide |
| 01/11/2006 | EP1613345A2 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
| 01/11/2006 | EP1613338A2 Tamandarin analogs and fragments thereof and methods of making and using |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1613268A2 Methods for inhibition of angiogenesis |
| 01/11/2006 | EP1613205A2 Erbb surface receptor complexes as biomarkers |
| 01/11/2006 | EP1613204A2 Assessing neuronal damage from blood samples |
| 01/11/2006 | EP1556084A4 Methods of regulating body weight |
| 01/11/2006 | EP1303540B1 Multi-specific reagent for selective stimulation of cell surface receptors |
| 01/11/2006 | EP1240328B1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 01/11/2006 | EP1144452B1 Modified antibodies and antibody fragments with increased duration of activity |
| 01/11/2006 | EP1129198B1 Polypeptide compositions toxic to diabrotica insects, obtained from bacillus thuringiensis; cryet70, and methods of use |
| 01/11/2006 | EP1127064B1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 01/11/2006 | EP1063294B1 Dnas or genes participating in parkinson's disease |
| 01/11/2006 | EP1009768B1 Human persephin |
| 01/11/2006 | EP0868519B1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 01/11/2006 | EP0830450B1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof |
| 01/11/2006 | EP0823913B1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 01/11/2006 | EP0787142B1 Neurturin and related growth factors |
| 01/11/2006 | EP0776972B1 GENE CODING FOR IgG-Fc-BINDING PROTEIN |
| 01/11/2006 | EP0731636B1 Cdn apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720336A Use of A33 antigens and JAM-IT |
| 01/11/2006 | CN1720263A Trimeric binding proteins for trimeric cytokines |
| 01/11/2006 | CN1718730A Anti tumour fusion protein and its coding gene and application |
| 01/11/2006 | CN1718588A Monoclone antibody for anti HLA-G and hybrid tumour cell secreting same, cancer dignosis method, diagnosis reagent box and its application |
| 01/11/2006 | CN1718587A Ant CD20 chimeric antibody |
| 01/11/2006 | CN1235911C Multiple cytokine-antibody complexes |
| 01/10/2006 | US6984721 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins GP300, P200, and P90/80 |
| 01/10/2006 | US6984720 cytotoxic t lymphocytes; immunology |
| 01/10/2006 | US6984719 Peptide antagonists of prostaglandin F2α receptor |
| 01/10/2006 | US6984625 Methods and compositions for modulating autoimmunity |
| 01/10/2006 | US6984621 Wound contraction inhibitor |
| 01/10/2006 | US6984501 used in test systems which are suitable for identifying substances modulating, opening or closing the Kv2,1/Kv6.2 channels and which can be used as therapeutic agents |
| 01/10/2006 | US6984492 administering intravenously a composition comprising monomeric IgA, dimeric IgA, and IgG prepared from pooled human plasma, wherein monomeric and dimeric IgA comprise at least 35% to 55% of total immunoglobulins present in composition |
| 01/10/2006 | US6984488 Determination and control of bimolecular interactions |
| 01/10/2006 | US6984487 Cystic fibrosis gene |
| 01/10/2006 | US6984383 Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins |
| 01/10/2006 | US6984382 Bifunctional protein, preparation and use |
| 01/10/2006 | CA2114353C Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 01/07/2006 | CA2509632A1 Me-5, me-2, and epp2: human protein antigens reactive with autoantibodies present in the serum of woman suffering from endometriosis |
| 01/06/2006 | CA2471063A1 Novel tfiih subunit |